Skip to content
10-K

Annual Report

PEGASUS MEDICAL HOLDINGS, INC.

0001140361-22-011693

← back to feed
Filed
Mar 30, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 31, 2022 1M sh
Operating Cash Flow FY 2021 · Dec 31, 2021 −$30.16K
Operating Cash Flow FY 2021 · Dec 31, 2020 $14.39K
Cash And Equivalents FY 2021 · Dec 31, 2021 $13.35K
Cash And Equivalents FY 2021 · Dec 31, 2020 $43.51K
Cash And Equivalents FY 2021 · Dec 31, 2019 $29.12K
Stockholders Equity FY 2021 · Dec 31, 2021 $6.2K
Stockholders Equity FY 2021 · Dec 31, 2020 $8.34K
Stockholders Equity FY 2021 · Dec 31, 2019 $10.89K
Stockholders Equity FY 2021 · Dec 31, 2018 $0
Current Liabilities FY 2021 · Dec 31, 2021 $7.15K
Current Liabilities FY 2021 · Dec 31, 2020 $35.17K
Current Assets FY 2021 · Dec 31, 2021 $13.35K
Current Assets FY 2021 · Dec 31, 2020 $43.51K
Total Assets FY 2021 · Dec 31, 2021 $13.35K
Total Assets FY 2021 · Dec 31, 2020 $43.51K
Net Income FY 2021 · Dec 31, 2021 −$37.14K
Net Income FY 2021 · Dec 31, 2020 −$2.55K
Net Income FY 2021 · Dec 31, 2019 −$250.16M
Operating Income FY 2021 · Dec 31, 2021 −$37.14K
Operating Income FY 2021 · Dec 31, 2020 −$2.55K